<DOC>
	<DOCNO>NCT00843934</DOCNO>
	<brief_summary>The purpose study compare efficacy safety cisplatin ( CDDP ) epirubicin ( EPI ) treatment transcatheter chemoembolization Hepatocellular Carcinoma ( HCC ) .</brief_summary>
	<brief_title>Trial Transcatheter Arterial Chemoembolization Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Subject must histologically clinically proven HCC , inoperable , indication local treatment measurable lesion . Subject must first experience TACE . Subject extrahepatic tumor obstruction main portal vein . Subjects must fully recover previous treatment ( least 4 week interval need prior chmotherapy radiation therapy ) . ECOG performance status 02 Childpugh Class A B Subject must adequate function bonemarrow , renal , circulatory organ appropriate examination result : 1 . Serum Total Bilirubin 2.0mg/mL 2 . WBC 3000/mm3 3 . PLT 50000/mm3 4 . Hb 9.0g/dL 5 . Creatinine ; upper normal limit ( UNL ) 6 . BUN 25mg/dL Written inform consent Subject extra hepatic metastasis . Tumor thrombosis exist main portal vein . Remarkable arteryportal vein shunt venoarterial shunt . Uncontrollable ascites pleural effusion . History severe hypersensitivity . Any previous TACE TAE HCC . Any previous chemotherapy use epirubicin CDDP . Complications ( except chronic hepatitis liver cirrhosis ) 1 . Severe heart disease 2 . Myocardial infarction within 6 month 3 . Renal insufficiency 4 . Active infection ( except virous hepatitis ) 5 . Gastrointestinal bleed 6 . Active double cancer 7 . Hepatic encephalopathy heavy mental disorder . Pregnancy lactation woman , woman suspect pregnancy men willing get pregnant . Any subject judged investigator unfit reason participate study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Carcinoma , Hepatocellular</keyword>
	<keyword>Trans arterial chemoembolization</keyword>
	<keyword>Epirubicin</keyword>
	<keyword>Cisplatin</keyword>
</DOC>